⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RVMD News
Revolution Medicines, Inc. Common Stock
Erasca, Inc. (ERAS) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before August 10, 2026
accessnewswire.com
ERAS
RVMD
Lost Money on Erasca, Inc. (ERAS)? Join Class Action Before August 10, 2026 - Contact Levi & Korsinsky
accessnewswire.com
ERAS
RVMD
Join Class Action to Recover Losses From Erasca, Inc. (ERAS) - Contact Levi & Korsinsky Before August 10, 2026
accessnewswire.com
ERAS
RVMD
Securities Class Action Lawsuit Filed Against Erasca, Inc. (ERAS) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
ERAS
RVMD
The Lustgarten Foundation Honors Pioneers in Pancreatic Cancer Research at Annual Inspiring Hope Gala
prnewswire.com
ERAS
RVMD
ERAS ALERT: Securities Fraud Class Action Launched Against Erasca, Inc. - August 10, 2026 Deadline
accessnewswire.com
ERAS
RVMD
Contact Levi & Korsinsky by August 10, 2026 to Join Class Action Against Erasca, Inc. (ERAS)
accessnewswire.com
ERAS
RVMD
Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
ERAS
RVMD
ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ERAS
RVMD
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
globenewswire.com
RVMD
MRNA
SRPT